organophosphonates has been researched along with AIDS-Related Opportunistic Infections in 171 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 89 (52.05) | 18.2507 |
| 2000's | 67 (39.18) | 29.6817 |
| 2010's | 14 (8.19) | 24.3611 |
| 2020's | 1 (0.58) | 2.80 |
| Authors | Studies |
|---|---|
| Armbrust, KR; Koozekanani, D; Santilli, CM | 1 |
| Cardoso, SV; de Faria, PR; Loyola, AM; Servato, JP; Spini, PH; Spini, TH | 1 |
| Allen, ME; Brown, J; Karakas, SE; Pollard, RB | 1 |
| Agut, H; Boutolleau, D; Burrel, S; Caumes, E; Epelboin, L; Katlama, C; Regnier, S; Seang, S; Valantin, MA; Voujon, D | 1 |
| Arnold, V; Barcellos, NT; Brites, C; Chêne, G; De Castro, N; Delaugerre, C; Fagard, C; Grinsztejn, B; Madruga, JV; Molina, JM; Morgado, M; Patey, O; Pilotto, JH; Santini-Oliveira, M; Santos, BR; Veloso, VG; Vorsatz, C | 1 |
| Ammassari, A; Antinori, A; Berenguer, J; Cingolani, A; Cinque, P; De Luca, A; Di Giambenedetto, S; Gasnault, J; Marra, CM; Miralles, P; Pezzotti, P; Taoufik, Y | 1 |
| Hernández, JM; Jarilla, F; Romero, E | 1 |
| Yoganathan, K | 1 |
| Lavae-Mokhtari, M; Mohammad-Khani, S; Schmidt, RE; Stoll, M | 1 |
| Battegay, M; Bernasconi, E; Cavassini, M; Elzi, L; Furrer, H; Hirschel, B; Ledergerber, B; Marzolini, C; Vernazza, P; Weber, R | 1 |
| Bernardin, R; Castelo-Soccio, L; Goldstein, SA; Kovarik, C; Stern, J | 1 |
| Kaul, R; Raboud, JM; Tan, DH; Walmsley, SL | 1 |
| Collette, DC; Zechel, MA | 1 |
| Beadsworth, MB; Pennell, A; Phillips, M; Ratcliffe, L; Vilar, FJ | 1 |
| Alsina-Gibert, M; Cañadas, MP; Darwich, E; Darwich, L; Ercilla, G; Klaustermeier, J; Mascaró, JM | 1 |
| Bazewicz, M; Caspers, L; Fikri, J; Frippiat, F; Libois, A; Martin, CH; Meunier, A; Willermain, F | 1 |
| Avril, MF; Dallot, A; Di Lucca-Christment, J; Dupin, N; Gressier, L; Jacobelli, S; Laude, H; Morini, JP; Plantier, F; Rosenberg, F; Rozenberg, F | 1 |
| Bellamy, S; Bisson, GP; Gluckman, S; Molefi, M; Rantleru, T; Ravimohan, S; Steenhoff, A; Tamuhla, N; Tebas, P; Thakur, R; Tsimako, I; Weissman, D | 1 |
| Ambrosioni, J; Calmy, A; Daou, S; Merkler, D | 1 |
| Kimberlin, DW | 1 |
| Emery, VC; Leśnikowski, ZJ; Olejniczak, A; Paradowska, E; Przepiórkiewicz, M | 1 |
| Chialant, D; Damji, KF; Hodge, WG; Wang, L | 1 |
| Duncan, BA; Ingrosso, A; Mucci, M; Nickens, DJ; Rodríguez, CA; Wolf, DL | 1 |
| Carmichael, A; Lever, AM; Roberts, MT | 1 |
| Gerding, H; Hackethal, U; Holzapfel, C; Husstedt, IW | 1 |
| Chiambaretta, F; Jacomet, C; Ménérath, JM; Pilon, F; Rapp, P | 1 |
| Azen, SP; Buley, A; Chaidhawangul, S; Cheng, L; Freeman, WR; Ozerdem, U; Scholz, B; Song, MK; Torriani, F | 1 |
| Hivnor, C; Shapiro, MS; Shepard, JW; Vittorio, CC | 1 |
| Baxter, KF; Highet, AS | 1 |
| Abrams, EJ; Ainyette, I; Champion, SE; Chiriboga, CA; DiGrado, M; Robinson, LG | 1 |
| Dunn, JP; Foster, G; Jabs, DA; Kuppermann, BD; Martin, DF; Van Natta, M; Zong, A | 1 |
| Meyerle, JH; Turiansky, GW | 1 |
| Danta, M; Dusheiko, G | 1 |
| Däumer, M; Kaiser, R; Matz, B; Rockstroh, JK; Schewe, CK; Schildgen, O; Vogel, M; Weitner, L | 1 |
| Hummel, M; Husak, R; Orfanos, CE; Sander-Bähr, C; Zouboulis, CC | 1 |
| Benhamou, Y; Biao, L; Brosgart, C; Calvez, V; Chang, CG; Currie, G; Fievet, MH; Marcelin, AG; Poynard, T; Thibault, V; Vig, P; Xiong, S | 1 |
| Thio, CL | 1 |
| Beeching, NJ; Douthwaite, ST; Hart, IJ; Mwandumba, HC; Stow, R; Taegtmeyer, M | 1 |
| Dieterich, DT; Freeman, WR; Friedberg, DN; Holland, GN; Jabs, DA; Kempen, JH; Min, YI | 1 |
| Arsura, E; Karter, D; Sethi, N; Torgovnick, J | 1 |
| Benhamou, Y | 1 |
| Diller, R; Thompson, K | 1 |
| Murayama, S; Saito, Y | 1 |
| Kishida, S | 1 |
| Bandt, D; Ehninger, G; Hochauf, K; Jacobs, E; Pöhlmann, C; Rohayem, J; Röllig, C; Schetelig, J; Wunderlich, O | 1 |
| Briand, S; Milpied, B; Navas, D; Stalder, JF; Thomare, P | 1 |
| Cundy, KC; Fisher, PE; Flaherty, J; Hitchcock, MJ; Jaffe, HS; Lalezari, JP; Lietman, PS; Petty, BG; Polis, MA; Wachsman, M | 1 |
| Andrei, G; Clumeck, N; De Clercq, E; De Wit, S; Poncin, M; Snoeck, R; Van Ranst, M | 1 |
| Cundy, K; Drew, WL; Fisher, PE; Flaherty, J; Glutzer, E; Hannigan, J; James, C; Lalezari, JP; Martin, JC; Miner, D | 1 |
| Arevalo, JF; Chavez de la Paz, E; De Clercq, E; Freeman, WR; Garcia, R; Kirsch, LS; Munguia, D | 1 |
| Cohen, J | 1 |
| Masur, H; Polis, MA | 1 |
| Arevalo, JF; Chavez de la Paz, E; de Clercq, E; Freeman, WR; Kirsch, LS; Munguia, D | 1 |
| Andrei, G; Balzarini, J; Clumeck, N; De Clercq, E; Gérard, M; Hedderman, A; Sadzot-Delvaux, C; Silverman, A; Snoeck, R; Tricot, G | 1 |
| Davidson, JM; Drew, WL; Fisher, PE; Glutzer, E; Jaffe, HS; Lalezari, JP; Miner, D; Owen, WF; Safrin, S | 1 |
| Andrei, G; Clumeck, N; De Clercq, E; Gerard, M; Sadzot-Delvaux, C; Snoeck, R; Tricot, G | 1 |
| Cundy, KC; Hitchcock, MJ; Lee, WA; Lynch, G; Shaw, JP | 1 |
| Jabs, DA | 1 |
| Arevalo, JF; Azen, SP; Chavez de la Paz, E; Freeman, WR; Munguia, D; Rahhal, FM | 1 |
| Arevalo, JF; Azen, SP; Chavez de la Paz, E; Freeman, WR; Munguia, D; Rahhal, FM; Taskintuna, I | 1 |
| Freeman, WR | 1 |
| Schwartz, DM | 1 |
| Drew, WL; Holland, GN; Ives, DV; Jaffe, HS; Kramer, F; Kuppermann, BD; Lalezari, JP; Robinson, MR; Stagg, RJ; Youle, M | 1 |
| Hardy, WD | 1 |
| Kuppermann, BD | 1 |
| Lalezari, JP | 1 |
| Kuppermann, BD; Lalezari, JP | 1 |
| Arevalo, JF; Chavez-de la Paz, E; De Clercq, E; Freeman, WR; Kirsch, LS; Munguia, D; Rahhal, FM | 1 |
| Cunningham, ET | 1 |
| Arevalo, JF; Banker, AS; De Clercq, E; Freeman, WR; Munguia, D; Rahhal, FM; Taskintuna, I | 1 |
| Jacobson, MA | 1 |
| Blick, G; Garton, T; Hopkins, U; LaGravinese, L | 1 |
| Gazzard, BG; Morris-Jones, S; Nelson, M; Sadler, M | 1 |
| Chou, S; Drew, WL; Follansbee, SE; Guentzel, S; Lalezari, JP; Marousek, G; Miner, RC; Poscher, ME | 1 |
| Katlama, C | 1 |
| Palau, LA; Pankey, GA; Tufty, GT | 1 |
| Vaghjimal, A | 1 |
| Arevalo, JF; Banker, AS; De Clercq, E; Freeman, WR; Mueller, AJ; Rahhal, FM; Rao, NA; Taskintuna, I; Wiley, CA | 1 |
| Ai, E; Freeman, WR; Mueller, AJ; Powell, HC; Rahhal, FM; Smith, IL; Spector, SA; Taskintuna, I | 1 |
| Smith, CL | 1 |
| Pau, AK | 1 |
| Hardy, WD; Holland, GN; Ives, DV; Jaffe, HS; Johnson, M; Kemper, CA; Kramer, F; Kuppermann, BD; Lalezari, JP; Lewis, RA; McKinley, GF; Nelson, R; Northfelt, DW; Ruby, AE; Simon, GL; Stagg, RJ; Weinberg, DV; Wolitz, RA; Youle, M | 1 |
| Chinn, R; Fisher, M; Gazzard, BG; Healy, J; Nelson, MR; Sadler, M | 1 |
| Akler, ME; Burman, WJ; Johnson, DW; Johnson, SC | 1 |
| Clark, NM; Greenson, JK; Hedderwick, SA; McGaughy, VR | 1 |
| Behnsch, M; Bergmann, F; Grobusch, MP; Liekfeld, A; Schürmann, D | 1 |
| Benson, CA; Deutsch, TA; Dieterich, DT; Drew, WL; Feinberg, J; Friedberg, DN; Griffiths, PD; Hardy, WD; Holland, GN; Jabs, DA; Jacobson, MA; Kessler, HA; Polis, MA; Powderly, WG; Spector, SA; Walmsley, S; Whitley, RJ | 1 |
| Freeman, WR; Karavellas, MP; Macdonald, JC; Morse, LS; Reed, JB; Torriani, FJ | 1 |
| Schleppy, CA; Tritten, JJ | 1 |
| Hammoud, Z; Parenti, DM; Simon, GL | 1 |
| Dunn, JP; Enger, C; Forman, M; Hubbard, L; Jabs, DA | 1 |
| Althaus, C; Hudde, T; Kersten, A; Pascha, G; Schweykart, N; Sundmacher, R | 1 |
| Cockerell, CJ; Zabawski, EJ | 1 |
| Delfraissy, JF; Dussaix, E; Gasnault, J; Goujard, C; Karaterki, A; Lannuzel, A; Marchadier, E; Pierre Ferey, M; Taoufik, Y | 1 |
| Avila, CP; Cheng, L; Freeman, WR; Keefe, KS; Macdonald, JC; Rao, NA | 1 |
| Bolton, SG; Dunn, JP; Jabs, DA; Palestine, AG | 1 |
| De Clercq, E; Noel, JC; Simonart, T; Snoeck, R | 1 |
| Azen, SP; Freeman, WR; Karavellas, MP; Macdonald, JC; Plummer, DJ; Shufelt, CL; Torriani, FJ | 1 |
| Engstrom, RE; Holland, GN; Lin, AP | 1 |
| Antinori, A; De Luca, A; Fantoni, M; Tartaglione, T | 1 |
| Mortimer, CB; Salit, IE; Tseng, AL | 1 |
| Cheung, TW; Teich, SA | 1 |
| Cherrington, J; Holtzer, C; Jacobson, MA; Safrin, S; Stanley, H; Wilson, S | 1 |
| Canzano, JC; Morse, LS; Wendel, RT | 1 |
| Abbed, K; Boue, F; Delfraissy, JF; Dussaix, E; Gasnault, J; Goujard, C; Kousignian, P; Taoufik, Y | 1 |
| Drew, WL; Lalezari, JP | 1 |
| Noble, S; Plosker, GL | 1 |
| Ambati, J; Angerame, MC; Robinson, MR; Wynne, KB | 1 |
| Adriani, B; Beretta, R; Cargnel, A; Fasolo, MM; Orlando, G; Signori, R; Zanchetta, N | 1 |
| Gümbel, HO; Rockstroh, JK; Schliefer, K; Spengler, U | 1 |
| Althaus, C; Best, J; Kersten, AJ; Sundmacher, R | 1 |
| Hoy, J | 1 |
| Cherrington, J; Jaffe, HS; Safrin, S | 1 |
| Besselmann, M; Happe, S; Husstedt, IW; Matheja, P; Reichelt, D; Rickert, CH; Schuierer, G | 1 |
| Berenguer, J; Mallolas, J | 1 |
| Chocarro Martinez, A; Garcia Garcia, I; Gonzalez Lopez, A | 1 |
| Ainsworth, J; Bainbridge, JW; Pinching, AJ; Raina, J; Shah, SM | 1 |
| Garweg, JG | 1 |
| Delfraissy, JF; Frau, E; Gasnault, J; Goujard, C; Labetoulle, M; Offret, H | 1 |
| Bergmann, F; Grobusch, MP; Schürmann, D; Suttorp, N; Temmesfeld-Wollbrück, B | 1 |
| Botsis, C; Kyriakis, KP; Paparizos, VA; Papastamopoulos, V; Stavrianeas, NG; Zagoraios, Y | 1 |
| Davis, MD; Gostout, BS; McGovern, RM; Persing, DH; Pittelkow, MR; Schut, RL | 1 |
| Patel, NK; Toro, JR; Turner, ML; Wood, LV | 1 |
| Althaus, C; Best, J; Gantke, B; Kersten, A; Theisen, A | 1 |
| Pavesio, C; Scott, RA | 1 |
| Boix, V; Merino, E; Portilla, J; Reus, S; Román, F | 1 |
| de Górgolas Hernández-Mora, M; Fernández Guerrero, ML; Nodar, A; Seijas, M | 1 |
| Agbalika, F; Hocqueloux, L; Molina, JM; Oksenhendler, E | 1 |
| Castillo, A; García Feijoó, J; García Sánchez, J; Martínez de la Casa, JM; Matilla Rodero, M | 1 |
| Blanchet, KD | 1 |
| Cheng, B | 1 |
| Feinberg, J | 1 |
| Torres, G | 1 |
| Smart, T | 1 |
| Highleyman, L | 1 |
| Bowers, M | 1 |
| Cadman, J | 1 |
| Cordero, E; de Alarcón, A; Herrero-Romero, M; López-Cortés, LF; Pachón, J | 1 |
| Korobelnik, JF; Lacut, Y; Le Rebeller, MJ; Neau, D; Ragnaud, JM; Rougier, MB; Viallard, JF | 1 |
| Haas, J; Hartmann, M; Stingele, K; von Einsiedel, R; Wildemann, B; Zimmermann, T | 1 |
| Calista, D | 1 |
| Lee, TA; Malinverni, R; Pleil, AM; Ramsey, SD; Steger, PJ; Sullivan, SD; Veenstra, DL; Williamson, T | 1 |
| Bertelli, D; Bestetti, A; Cinque, P; Fausti, C; Lazzarin, A; Pierotti, C; Viganò, MG | 1 |
| Alba, L; Ammassari, A; Antinori, A; Cauda, R; Cingolani, A; De Luca, A; Giancola, ML; Grisetti, S; Ippolito, G; Larussa, D; Monforte, A; Murri, R | 1 |
| Delfraissy, JF; Gasnault, J; Kahraman, M; Kousignian, P; Matheron, S; Rahoiljaon, J; Taoufik, Y | 1 |
| Andreoni, M; Carolo, G; Concia, E; Gatti, F; Mazzi, R; Nicastri, E; Parisi, SG; Sarmati, L; Uccella, I | 1 |
| Aksamit, AJ; Razonable, RR; Wilson, JW; Wright, AJ | 1 |
| Salmon-Ceron, D | 1 |
| Soltau, JB | 1 |
| Accorinti, M; Ciapparoni, V; Pirraglia, MP; Pivetti-Pezzi, P | 1 |
| Wilcox, RD | 1 |
| Farese, A; Giorgini, S; Martinelli, C; Mistro, AD; Ruffino, I | 1 |
| Bestman-Smith, J; Boivin, G | 1 |
| Williams, IG | 1 |
| Di Perri, G; Maiello, A; Quario, M; Racca, D; Sinicco, A; Zeme, DA | 1 |
| Geusau, A; Kopp, T; Rieger, A; Stingl, G | 1 |
30 review(s) available for organophosphonates and AIDS-Related Opportunistic Infections
| Article | Year |
|---|---|
BILATERAL UVEITIS AND HYPOTONY FOLLOWING TREATMENT WITH TOPICAL CIDOFOVIR.
Topics: AIDS-Related Opportunistic Infections; Choroidal Effusions; Cidofovir; Cytosine; Humans; Male; Middle Aged; Ocular Hypotension; Organophosphonates; Uveitis; Uveitis, Anterior | 2023 |
Novel treatment of atypical human papillomavirus-associated epithelial hyperplasia with cidofovir.
Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Anus Neoplasms; Cidofovir; Cytosine; Epithelium; Fatal Outcome; HIV Infections; Humans; Male; Middle Aged; Molecular Structure; Mouth Diseases; Mouth Mucosa; Organophosphonates; Papillomavirus Infections | 2011 |
Intracranial hypertension following highly active antiretroviral therapy interruption in an HIV-infected woman: case report and review of the literature.
Topics: Acquired Immunodeficiency Syndrome; Adenine; Adult; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Darunavir; Decompressive Craniectomy; Dideoxynucleosides; Female; Humans; Intracranial Hypertension; Lopinavir; Medication Adherence; Meningoencephalitis; Organophosphonates; Sulfonamides; Tenofovir; Treatment Outcome | 2013 |
[Drugs against human cytomegalovirus].
Topics: Acyclovir; AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Cytomegalovirus Infections; Cytosine; Drugs, Investigational; Female; Foscarnet; Ganciclovir; Global Health; Humans; Infectious Disease Transmission, Vertical; Naphthalenesulfonates; Organophosphonates; Organophosphorus Compounds; Pregnancy; Pregnancy Complications, Infectious; Thionucleotides; Valacyclovir; Valganciclovir; Valine | 2002 |
[Ocular complications of the virostatic drug cidofovir].
Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Cytomegalovirus Retinitis; Cytosine; Eye Diseases; Humans; Infusions, Intravenous; Injections; Leukoencephalopathy, Progressive Multifocal; Ocular Hypotension; Organophosphonates; Organophosphorus Compounds; Uveitis, Anterior; Vitreous Body | 2003 |
Adefovir dipivoxil: review of a novel acyclic nucleoside analogue.
Topics: Adenine; AIDS-Related Opportunistic Infections; Antiviral Agents; Drug Resistance, Viral; Hepatitis B, Chronic; HIV Infections; Humans; Organophosphonates; Treatment Outcome | 2004 |
[Treating chronic lamivudine-resistant hepatitis B in HIV co-infected patients].
Topics: Adenine; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antiviral Agents; Drug Resistance, Viral; Drug Therapy, Combination; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Organophosphonates; Reverse Transcriptase Inhibitors; Tenofovir; Treatment Outcome | 2006 |
[Neuropathology of progressive multifocal leukoencephalopathy].
Topics: AIDS-Related Opportunistic Infections; Antiretroviral Therapy, Highly Active; Antiviral Agents; Brain; Cidofovir; Cytarabine; Cytosine; Demyelinating Diseases; Humans; JC Virus; Leukoencephalopathy, Progressive Multifocal; Oligodendroglia; Organophosphonates | 2007 |
[Progressive multifocal leukoencephalopathy--epidemiology, clinical pictures, diagnosis and therapy].
Topics: AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Antiviral Agents; Biomarkers; Cidofovir; Cytarabine; Cytosine; DNA, Viral; Humans; Japan; JC Virus; Leukoencephalopathy, Progressive Multifocal; Organophosphonates; Prognosis; Tomography, X-Ray Computed | 2007 |
Promising new treatments for cytomegalovirus retinitis.
Topics: AIDS-Related Opportunistic Infections; Cidofovir; Cytomegalovirus Retinitis; Cytosine; Drug Implants; Foscarnet; Ganciclovir; Humans; Injections, Intralesional; Organophosphonates; Organophosphorus Compounds | 1995 |
New therapies for cytomegalovirus retinitis.
Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Cytomegalovirus Retinitis; Cytosine; Drug Administration Routes; Drug Therapy, Combination; Ganciclovir; Humans; Organophosphonates; Organophosphorus Compounds; Treatment Outcome | 1996 |
Management strategies for patients with cytomegalovirus retinitis.
Topics: Administration, Oral; AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Cytomegalovirus Retinitis; Cytosine; Drug Implants; Drug Interactions; Drug Therapy, Combination; Foscarnet; Ganciclovir; Humans; Infusions, Intravenous; Organophosphonates; Organophosphorus Compounds | 1997 |
Therapeutic options for resistant cytomegalovirus retinitis.
Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Cytomegalovirus; Cytomegalovirus Retinitis; Cytosine; Drug Implants; Drug Resistance, Microbial; Drug Therapy, Combination; Foscarnet; Ganciclovir; Humans; Infusions, Intravenous; Organophosphonates; Organophosphorus Compounds; Recurrence; Thionucleotides | 1997 |
Cidofovir: a new therapy for cytomegalovirus retinitis.
Topics: AIDS-Related Opportunistic Infections; Animals; Antiviral Agents; Cidofovir; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Cytomegalovirus Retinitis; Cytosine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; Kidney; Organophosphonates; Organophosphorus Compounds; Probenecid; Renal Agents | 1997 |
Clinical experience with cidofovir in the treatment of cytomegalovirus retinitis.
Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Cytomegalovirus Retinitis; Cytosine; Humans; Kidney; Organophosphonates; Organophosphorus Compounds | 1997 |
Treatment of cytomegalovirus retinitis in patients with the acquired immunodeficiency syndrome.
Topics: Administration, Oral; AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Cytomegalovirus Retinitis; Cytosine; Drug Implants; Drug Therapy, Combination; Foscarnet; Ganciclovir; Humans; Organophosphonates; Organophosphorus Compounds | 1997 |
Management of CMV retinitis in HIV infected patients.
Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Clinical Trials as Topic; Cytomegalovirus Retinitis; Cytosine; Foscarnet; Ganciclovir; Guanine; Humans; Organophosphonates; Organophosphorus Compounds; Prodrugs; Prospective Studies; Recurrence | 1997 |
Local therapy for cytomegalovirus retinitis.
Topics: Administration, Topical; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antiviral Agents; Cidofovir; Cytomegalovirus Retinitis; Cytosine; Foscarnet; Ganciclovir; Humans; Organophosphonates; Organophosphorus Compounds; Vitreous Body | 1998 |
Topical and intralesional cidofovir: a review of pharmacology and therapeutic effects.
Topics: Administration, Cutaneous; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antiviral Agents; Cidofovir; Cytomegalovirus Retinitis; Cytosine; Herpesviridae Infections; Humans; Injections, Intralesional; Injections, Intravenous; Molluscum Contagiosum; Organophosphonates; Organophosphorus Compounds; Papillomaviridae; Papillomavirus Infections; Sarcoma, Kaposi; Skin Diseases, Viral; Skin Neoplasms; Tumor Virus Infections | 1998 |
Cytomegalovirus infection in patients with HIV infection.
Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Cytomegalovirus Infections; Cytosine; Foscarnet; Ganciclovir; Humans; Organophosphonates; Organophosphorus Compounds | 1999 |
Cytomegalovirus: disease syndromes and treatment.
Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Central Nervous System Diseases; Chorioretinitis; Cidofovir; Cytomegalovirus Infections; Cytosine; Drug Resistance; Foscarnet; Ganciclovir; Gastrointestinal Diseases; Humans; Organophosphonates; Organophosphorus Compounds; Pneumonia; Sexually Transmitted Diseases, Viral | 1999 |
Cidofovir: a review of its use in cytomegalovirus retinitis in patients with AIDS.
Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Clinical Trials as Topic; Cytomegalovirus Retinitis; Cytosine; Humans; In Vitro Techniques; Organophosphonates; Organophosphorus Compounds | 1999 |
Management of CMV infections in HIV-infected patients.
Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Cytomegalovirus Retinitis; Cytosine; Foscarnet; Ganciclovir; Humans; Organophosphonates; Organophosphorus Compounds | 1999 |
Cidofovir. Review of current and potential clinical uses.
Topics: AIDS-Related Opportunistic Infections; Animals; Antiviral Agents; Cidofovir; Clinical Trials as Topic; Cytomegalovirus; Cytomegalovirus Infections; Cytomegalovirus Retinitis; Cytosine; Humans; Organophosphonates; Organophosphorus Compounds | 1999 |
[Cidofovir (vistide) in therapy of progressive multifocal leukoencephalopathy in AIDS. Review of the literature and report of 2 cases].
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Brain; Cidofovir; Cytosine; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Leukoencephalopathy, Progressive Multifocal; Magnetic Resonance Imaging; Male; Organophosphonates; Organophosphorus Compounds; Tomography, Emission-Computed | 1999 |
[Anterior segment involvement in HIV-related eye disease after the commencement of highly active antiretroviral therapy (HAART)].
Topics: AIDS-Related Opportunistic Infections; Animals; Anti-HIV Agents; Antibiotics, Antitubercular; Cidofovir; Cytosine; Diagnosis, Differential; Drug Therapy, Combination; Eye Diseases; Humans; Organophosphonates; Organophosphorus Compounds; Rifabutin; Uveitis | 2000 |
[Ocular complications after treatment with intravenous cidofovir for cytomegalovirus retinitis].
Topics: Acute Disease; Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Cytomegalovirus Retinitis; Cytosine; Humans; Injections, Intravenous; Male; Ocular Hypotension; Organophosphonates; Organophosphorus Compounds; Uveitis, Anterior | 2001 |
Economic evaluation of systemic treatments for cytomegalovirus retinitis in patients with AIDS.
Topics: Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Cytomegalovirus Retinitis; Cytosine; Economics, Pharmaceutical; Foscarnet; Ganciclovir; Humans; Models, Economic; Organophosphonates; Organophosphorus Compounds; Switzerland; Treatment Failure | 2001 |
Cytomegalovirus infection: the point in 2001.
Topics: AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Antiviral Agents; CD4 Lymphocyte Count; Cidofovir; Cytomegalovirus Infections; Cytosine; Drug Monitoring; Foscarnet; Ganciclovir; Humans; Organophosphonates; Organophosphorus Compounds; Polymerase Chain Reaction; Population Surveillance; Predictive Value of Tests; Prevalence; Risk Factors; Valganciclovir | 2001 |
Management of CMV disease in HIV infection.
Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Cytomegalovirus Infections; Cytomegalovirus Retinitis; Cytosine; Encephalitis, Viral; Foscarnet; Ganciclovir; Gastrointestinal Diseases; Humans; Organophosphonates; Organophosphorus Compounds | 1999 |
23 trial(s) available for organophosphonates and AIDS-Related Opportunistic Infections
| Article | Year |
|---|---|
Raltegravir for the treatment of patients co-infected with HIV and tuberculosis (ANRS 12 180 Reflate TB): a multicentre, phase 2, non-comparative, open-label, randomised trial.
Topics: Adenine; Adult; AIDS-Related Opportunistic Infections; Alkynes; Anti-HIV Agents; Antitubercular Agents; Benzoxazines; Brazil; Coinfection; Cyclopropanes; Drug Therapy, Combination; Female; France; HIV Infections; HIV-1; Humans; Lamivudine; Male; Middle Aged; Organophosphonates; Pyrrolidinones; Raltegravir Potassium; RNA, Viral; Tenofovir; Treatment Outcome; Tuberculosis; Viral Load | 2014 |
Early versus delayed antiretroviral therapy and cerebrospinal fluid fungal clearance in adults with HIV and cryptococcal meningitis.
Topics: Adenine; Adult; AIDS-Related Opportunistic Infections; Alkynes; Amphotericin B; Anti-HIV Agents; Antifungal Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; Colony Count, Microbial; Cyclopropanes; Deoxycytidine; Emtricitabine; Female; Humans; Immune Reconstitution Inflammatory Syndrome; Male; Meningitis, Cryptococcal; Organophosphonates; Survival Analysis; Tenofovir; Treatment Outcome | 2013 |
Pharmacokinetics and renal effects of cidofovir with a reduced dose of probenecid in HIV-infected patients with cytomegalovirus retinitis.
Topics: Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Cytomegalovirus Retinitis; Cytosine; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Kidney; Male; Middle Aged; Organophosphonates; Organophosphorus Compounds; Probenecid | 2003 |
Complications of ganciclovir implant surgery in patients with cytomegalovirus retinitis: the Ganciclovir Cidofovir Cytomegalovirus Retinitis Trial.
Topics: Administration, Oral; Adult; AIDS-Related Opportunistic Infections; Anesthesia, General; Anesthesia, Local; Antiviral Agents; Cidofovir; Cytomegalovirus Retinitis; Cytosine; Drug Implants; Female; Ganciclovir; Humans; Infusions, Intravenous; Intraoperative Complications; Male; Organophosphonates; Organophosphorus Compounds; Postoperative Complications; Prospective Studies; Visual Acuity; Vitreous Hemorrhage | 2004 |
(S)-1-[3-hydroxy-2-(phosphonylmethoxy)propyl]cytosine (cidofovir): results of a phase I/II study of a novel antiviral nucleotide analogue.
Topics: Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Creatine; Cytomegalovirus Infections; Cytosine; DNA, Viral; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; Kidney; Male; Middle Aged; Organophosphonates; Organophosphorus Compounds; Probenecid; Proteinuria; Semen; Virus Shedding | 1995 |
Phase I/II study of intravitreal cidofovir for the treatment of cytomegalovirus retinitis in patients with the acquired immunodeficiency syndrome.
Topics: Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Cytomegalovirus Retinitis; Cytosine; Drug Tolerance; Female; Fundus Oculi; Humans; Injections; Male; Middle Aged; Ocular Hypotension; Organophosphonates; Organophosphorus Compounds; Survival Analysis; Vitreous Body | 1995 |
Intravitreal cidofovir (HPMPC) treatment of cytomegalovirus retinitis in patients with acquired immune deficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Ciliary Body; Cytomegalovirus Retinitis; Cytosine; Drug Therapy, Combination; Female; Humans; Injections; Intraocular Pressure; Male; Middle Aged; Organophosphonates; Organophosphorus Compounds; Probenecid; Retina; Uveitis; Vitreous Body | 1995 |
Intravenous cidofovir for peripheral cytomegalovirus retinitis in patients with AIDS. A randomized, controlled trial.
Topics: Adolescent; Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Cytomegalovirus Retinitis; Cytosine; Disease Progression; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Organophosphonates; Organophosphorus Compounds; Prospective Studies; Visual Acuity | 1997 |
Parenteral cidofovir for cytomegalovirus retinitis in patients with AIDS: the HPMPC peripheral cytomegalovirus retinitis trial. A randomized, controlled trial. Studies of Ocular complications of AIDS Research Group in Collaboration with the AIDS Clinical
Topics: Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Combined Modality Therapy; Cytomegalovirus Retinitis; Cytosine; Disease Progression; Drug Administration Schedule; Female; Fluid Therapy; Humans; Kidney Diseases; Male; Organophosphonates; Organophosphorus Compounds; Probenecid; Prospective Studies; Renal Agents; Visual Acuity | 1997 |
Anterior nongranulomatous uveitis after intravitreal HPMPC (cidofovir) for the treatment of cytomegalovirus retinitis. Analysis and prevention.
Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Cytomegalovirus Retinitis; Cytosine; Glucocorticoids; Granuloma; Humans; Incidence; Injections; Iritis; Mydriatics; Organophosphonates; Organophosphorus Compounds; Probenecid; Prospective Studies; Uricosuric Agents; Vitreous Body | 1997 |
Randomized, controlled study of the safety and efficacy of intravenous cidofovir for the treatment of relapsing cytomegalovirus retinitis in patients with AIDS.
Topics: Adolescent; Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Creatinine; Cytomegalovirus Retinitis; Cytosine; Disease Progression; Drug Therapy, Combination; Female; Humans; Infusions, Intravenous; Intraocular Pressure; Kidney; Male; Middle Aged; Organophosphonates; Organophosphorus Compounds; Probenecid; Proteinuria; Recurrence; Renal Agents; Risk Factors; Visual Acuity | 1998 |
Phase I study of combination therapy with intravenous cidofovir and oral ganciclovir for cytomegalovirus retinitis in patients with AIDS.
Topics: Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Cytomegalovirus Retinitis; Cytosine; Drug Therapy, Combination; Female; Ganciclovir; Humans; Male; Middle Aged; Organophosphonates; Organophosphorus Compounds; Treatment Outcome | 1999 |
Long-term follow-up of patients with AIDS treated with parenteral cidofovir for cytomegalovirus retinitis: the HPMPC Peripheral Cytomegalovirus Retinitis Trial. The Studies of Ocular Complications of AIDS Research Group in collaboration with the AIDS Clin
Topics: Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Cytomegalovirus Retinitis; Cytosine; Female; Follow-Up Studies; Humans; Infusions, Intravenous; Male; Morbidity; Organophosphonates; Organophosphorus Compounds; Time Factors; Treatment Outcome; Vision, Ocular | 2000 |
The ganciclovir implant plus oral ganciclovir versus parenteral cidofovir for the treatment of cytomegalovirus retinitis in patients with acquired immunodeficiency syndrome: The Ganciclovir Cidofovir Cytomegalovirus Retinitis Trial.
Topics: Administration, Oral; Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Cytomegalovirus Retinitis; Cytosine; Disease Progression; Double-Blind Method; Drug Evaluation; Drug Implants; Female; Ganciclovir; Humans; Infusions, Parenteral; Kidney; Male; Organophosphonates; Organophosphorus Compounds; Survival Rate; Treatment Outcome; Uveitis; Visual Acuity; Vitreous Hemorrhage | 2001 |
SOCA research group stops enrollment. Studies of the Ocular Complications of AIDS.
Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Cytomegalovirus Retinitis; Cytosine; Humans; Infusions, Intravenous; Kidney; Organophosphonates; Organophosphorus Compounds | 1996 |
Hepatitis B and adefovir depivoxil.
Topics: Adenine; AIDS-Related Opportunistic Infections; Antiviral Agents; Controlled Clinical Trials as Topic; Hepatitis B; Hepatitis B virus; Humans; Organophosphonates; Treatment Outcome | 1997 |
NDA filed to treat refractory herpes.
Topics: Administration, Topical; AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Cytosine; Drug Approval; Herpes Simplex; Humans; Organophosphonates; Organophosphorus Compounds; Randomized Controlled Trials as Topic; Recurrence; United States; United States Food and Drug Administration | 1997 |
Update on treatment of CMV retinitis.
Topics: Administration, Oral; AIDS-Related Opportunistic Infections; Cidofovir; Cytomegalovirus Retinitis; Cytosine; Drug Implants; Eye; Ganciclovir; Humans; Infusions, Intravenous; Organophosphonates; Organophosphorus Compounds; Randomized Controlled Trials as Topic | 1995 |
Opportunistic infection highlights from the 35th ICAAC.
Topics: Acyclovir; AIDS-Related Opportunistic Infections; Antiviral Agents; Bacterial Vaccines; CD4 Lymphocyte Count; Cidofovir; Clinical Trials as Topic; Cytomegalovirus Infections; Cytosine; Drug Resistance, Microbial; Ganciclovir; HIV; Humans; Influenza Vaccines; Mycobacterium avium-intracellulare Infection; Organophosphonates; Organophosphorus Compounds; Pneumonia; Pneumonia, Pneumocystis; Randomized Controlled Trials as Topic; United States; Valacyclovir; Valine; Viremia | 1995 |
Cidofovir added to highly active antiretroviral therapy in AIDS-associated progressive multifocal leukoencephalopathy.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Cidofovir; Cytosine; Drug Therapy, Combination; Female; Humans; Leukoencephalopathy, Progressive Multifocal; Male; Organophosphonates; Organophosphorus Compounds | 2001 |
Topical cidofovir for severe cutaneous human papillomavirus and molluscum contagiosum infections in patients with HIV/AIDS. A pilot study.
Topics: Administration, Topical; Adult; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Cidofovir; Cytosine; Female; Follow-Up Studies; Humans; Male; Middle Aged; Molluscum Contagiosum; Organophosphonates; Organophosphorus Compounds; Papillomavirus Infections; Pilot Projects; Recurrence; Severity of Illness Index; Skin Diseases, Viral; Treatment Outcome; Tumor Virus Infections | 2000 |
Potent anti-retroviral therapy with or without cidofovir for AIDS-associated progressive multifocal leukoencephalopathy: extended follow-up of an observational study.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Antiretroviral Therapy, Highly Active; Antiviral Agents; Cidofovir; Cytosine; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Leukoencephalopathy, Progressive Multifocal; Male; Middle Aged; Organophosphonates; Organophosphorus Compounds; Survival Rate | 2001 |
Cidofovir in AIDS-associated progressive multifocal leukoencephalopathy: a monocenter observational study with clinical and JC virus load monitoring.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Antiretroviral Therapy, Highly Active; Antiviral Agents; Cidofovir; Cytosine; Drug Therapy, Combination; Female; Humans; JC Virus; Leukoencephalopathy, Progressive Multifocal; Male; Middle Aged; Organophosphonates; Organophosphorus Compounds; Prospective Studies; Survival Analysis; Viral Load | 2001 |
118 other study(ies) available for organophosphonates and AIDS-Related Opportunistic Infections
| Article | Year |
|---|---|
Regression of oral Kaposi's sarcoma after combination antiretroviral therapy.
Topics: Adenine; Adult; AIDS-Related Opportunistic Infections; Alkynes; Anti-Retroviral Agents; Benzoxazines; Cyclopropanes; Drug Therapy, Combination; Humans; Lamivudine; Male; Organophosphonates; Sarcoma, Kaposi; Tenofovir | 2013 |
Refractory AIDS cholangiopathy: metabolic complications and the role of plasmapheresis.
Topics: Abdominal Pain; Acquired Immunodeficiency Syndrome; Adenine; AIDS-Related Opportunistic Infections; CD4 Lymphocyte Count; Cholangitis; Deoxycytidine; Emtricitabine; Humans; Jaundice; Male; Organophosphonates; Plasmapheresis; Pyrrolidinones; Raltegravir Potassium; Tenofovir; Treatment Outcome; Viral Load; Young Adult | 2013 |
Long-term follow-up of HIV-infected patients once diagnosed with acyclovir-resistant herpes simplex virus infection.
Topics: Acyclovir; Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Cytosine; Drug Resistance, Viral; Female; Follow-Up Studies; Foscarnet; Herpes Simplex; HIV Infections; Humans; Immunocompromised Host; Male; Middle Aged; Organophosphonates; Retrospective Studies; Skin Diseases, Viral; Skin Ulcer; Socioeconomic Factors; Thymidine Kinase; Treatment Outcome | 2014 |
Cidofovir in addition to antiretroviral treatment is not effective for AIDS-associated progressive multifocal leukoencephalopathy: a multicohort analysis.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Retroviral Agents; Antiviral Agents; Cidofovir; Cohort Studies; Cytosine; Female; Humans; Leukoencephalopathy, Progressive Multifocal; Male; Morbidity; Odds Ratio; Organophosphonates; Proportional Hazards Models; Risk; Survival Analysis; Treatment Failure | 2008 |
[Renal tuberculosis and human immunodeficiency virus infection].
Topics: Acute Kidney Injury; Adenine; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Antitubercular Agents; Fatal Outcome; Humans; Kidney Diseases; Male; Middle Aged; Multiple Organ Failure; Organophosphonates; Pneumocystis carinii; Pneumonia, Pneumocystis; Recurrence; Renal Dialysis; Tenofovir; Trimethoprim, Sulfamethoxazole Drug Combination; Tuberculosis, Renal | 2009 |
Long-term suppressive therapy for pulmonary aspergilloma in an immunocompromised man with AIDS. Is it always necessary?
Topics: Adenine; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antifungal Agents; Aspergillosis; Didanosine; Drug Administration Schedule; Drug Interactions; Fatal Outcome; HIV Infections; Humans; Immunocompromised Host; Lung Diseases, Fungal; Male; Middle Aged; Organophosphonates; Pancreatitis; Radiography; Reverse Transcriptase Inhibitors; Tenofovir; Treatment Outcome | 2009 |
[Telbivudine in the management of HIV/HBV coinfection. Treating hepatitis B without HIV trouble].
Topics: Adenine; AIDS-Related Opportunistic Infections; Algorithms; Anti-HIV Agents; Antiviral Agents; Comorbidity; DNA, Viral; Drug Resistance, Multiple, Viral; Drug Therapy, Combination; Hepatitis B virus; Hepatitis B, Chronic; Humans; Liver Function Tests; Nucleosides; Organophosphonates; Pyrimidinones; Telbivudine; Thymidine | 2009 |
[Acute renal failure and hypercalcemia in an AIDS patient on tenofovir and low-dose vitamin D therapy with immune reconstitution inflammatory syndrome].
Topics: Acquired Immunodeficiency Syndrome; Acute Kidney Injury; Adenine; Adrenal Cortex Hormones; Adult; AIDS-Related Opportunistic Infections; Alkynes; Anti-HIV Agents; Antitubercular Agents; Benzoxazines; Calcium; Cholecalciferol; Cyclopropanes; Deoxycytidine; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Emtricitabine; Female; Humans; Hypercalcemia; Immune Reconstitution Inflammatory Syndrome; Kidney Function Tests; Mycobacterium avium-intracellulare Infection; Organophosphonates; Osteoporosis; Tenofovir | 2009 |
Treatment modification in human immunodeficiency virus-infected individuals starting combination antiretroviral therapy between 2005 and 2008.
Topics: Adenine; Adult; AIDS-Related Opportunistic Infections; Alkynes; Anti-HIV Agents; Atazanavir Sulfate; Benzoxazines; Cyclopropanes; Deoxycytidine; Dideoxynucleosides; Drug Therapy, Combination; Emtricitabine; Female; HIV Infections; Humans; Lamivudine; Lopinavir; Male; Middle Aged; Nevirapine; Oligopeptides; Organophosphonates; Proportional Hazards Models; Prospective Studies; Pyridines; Pyrimidinones; Risk Factors; Switzerland; Tenofovir; Zidovudine | 2010 |
Successful treatment of acyclovir-resistant herpes simplex virus with intralesional cidofovir.
Topics: Acyclovir; Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Cytosine; Drug Resistance, Viral; Facial Dermatoses; Herpes Simplex; Humans; Injections, Intralesional; Male; Organophosphonates | 2010 |
No impact of oral tenofovir disoproxil fumarate on herpes simplex virus shedding in HIV-infected adults.
Topics: Adenine; Adult; AIDS-Related Opportunistic Infections; Canada; Female; Herpes Simplex; Herpesvirus 1, Human; Herpesvirus 2, Human; HIV Infections; HIV-1; Humans; Male; Middle Aged; Organophosphonates; Tenofovir; Virus Shedding | 2011 |
Managing hepatitis B/HIV co-infected: adding entecavir to truvada (tenofovir disoproxil/emtricitabine) experienced patients.
Topics: Adenine; Adult; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Deoxycytidine; DNA, Viral; Drug Administration Schedule; Drug Therapy, Combination; Emtricitabine; Guanine; Hepatitis B virus; Hepatitis B, Chronic; HIV Infections; Humans; Male; Middle Aged; Organophosphonates; Prospective Studies; Tenofovir; Treatment Outcome | 2011 |
New human papillomavirus (HPV) types involved in epidermodysplasia verruciformis (EV) in 3 HIV-infected patients: response to topical cidofovir.
Topics: Administration, Topical; Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Cytosine; Dose-Response Relationship, Drug; Drug Administration Schedule; Epidermodysplasia Verruciformis; Follow-Up Studies; Humans; Male; Middle Aged; Organophosphonates; Papillomaviridae; Papillomavirus Infections; Sampling Studies; Severity of Illness Index; Treatment Outcome | 2011 |
Drug-induced uveitis in aids patients: two case reports.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Cidofovir; Cytomegalovirus Retinitis; Cytosine; Female; Humans; Organophosphonates; Rifabutin; Uveitis | 2011 |
Anogenital pseudotumoral herpes and HIV infection: a new challenge for diagnosis and treatment.
Topics: Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Carcinoma, Squamous Cell; Cidofovir; Condylomata Acuminata; Cytosine; Diagnosis, Differential; Female; Foscarnet; Humans; Male; Middle Aged; Organophosphonates; Papillomavirus Infections; Thalidomide; Treatment Outcome; Tumor Virus Infections | 2012 |
Antiviral therapy for cytomegalovirus infections in pediatric patients.
Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Adolescent; Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Child; Child, Preschool; Cidofovir; Cytomegalovirus Infections; Cytosine; Foscarnet; Ganciclovir; Humans; Immunocompromised Host; Infant; Injections, Intravenous; Organophosphonates; Organophosphorus Compounds; Time Factors | 2002 |
Hypotony after intravenous cidofovir therapy for the treatment of cytomegalovirus retinitis.
Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Atrophy; Child; Cidofovir; Ciliary Body; Cytomegalovirus Retinitis; Cytosine; Humans; Infusions, Intravenous; Intraocular Pressure; Male; Ocular Hypotension; Organophosphonates; Organophosphorus Compounds; Ultrasonography | 2002 |
Prolonged survival in AIDS-related progressive multifocal leucoencephalopathy following anti-retroviral therapy and cidofovir.
Topics: Adult; AIDS-Related Opportunistic Infections; Antiretroviral Therapy, Highly Active; Antiviral Agents; Cerebrospinal Fluid; Cidofovir; Cytosine; Humans; JC Virus; Leukoencephalopathy, Progressive Multifocal; Male; Organophosphonates; Organophosphorus Compounds; Prognosis; Survival Rate; Treatment Outcome | 2003 |
[Bilateral uveitis with definitive hypotony caused by systemic cidofovir].
Topics: AIDS-Related Opportunistic Infections; Cidofovir; Ciliary Body; Cytomegalovirus Retinitis; Cytosine; Foscarnet; Humans; Injections, Intravenous; Male; Middle Aged; Necrosis; Ocular Hypotension; Organophosphonates; Organophosphorus Compounds; Uveitis, Anterior | 2003 |
Effect of anti-cytomegalovirus therapy on the incidence of immune recovery uveitis in AIDS patients with healed cytomegalovirus retinitis.
Topics: Adult; AIDS-Related Opportunistic Infections; Antiretroviral Therapy, Highly Active; Antiviral Agents; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; Cidofovir; Cytomegalovirus Retinitis; Cytosine; Epiretinal Membrane; Eye Diseases; Female; Humans; Incidence; Macular Edema; Male; Organophosphonates; Organophosphorus Compounds; Risk Factors; Uveitis; Vitreous Body | 2003 |
Intravenous cidofovir for recalcitrant verruca vulgaris in the setting of HIV.
Topics: Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Cytosine; Hand Dermatoses; Humans; Infusions, Intravenous; Male; Organophosphonates; Organophosphorus Compounds; Warts | 2004 |
Topical cidofovir and cryotherapy--combination treatment for recalcitrant molluscum contagiosum in a patient with HIV infection.
Topics: Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Combined Modality Therapy; Cryotherapy; Cytosine; Humans; Male; Molluscum Contagiosum; Organophosphonates; Organophosphorus Compounds | 2004 |
Progressive multifocal leukoencephalopathy successfully treated with highly active antiretroviral therapy and cidofovir in an adolescent infected with perinatal human immunodeficiency virus (HIV).
Topics: Adolescent; AIDS-Related Opportunistic Infections; Antiretroviral Therapy, Highly Active; Antiviral Agents; CD4 Lymphocyte Count; Cidofovir; Cytosine; Diagnosis, Differential; Follow-Up Studies; HIV Infections; HIV-1; Humans; Image Enhancement; Infectious Disease Transmission, Vertical; Leukoencephalopathy, Progressive Multifocal; Magnetic Resonance Imaging; Male; Neurologic Examination; Neuropsychological Tests; Organophosphonates; Organophosphorus Compounds; Treatment Outcome; Viral Load | 2004 |
Perianal ulcer in a patient with AIDS.
Topics: AIDS-Related Opportunistic Infections; Anti-HIV Agents; Cidofovir; Cytomegalovirus Infections; Cytomegalovirus Retinitis; Cytosine; Diagnosis, Differential; Fatal Outcome; Humans; Male; Middle Aged; Organophosphonates; Organophosphorus Compounds; Perineum; Skin Ulcer | 2004 |
Successful therapy of hepatitis B with tenofovir in HIV-infected patients failing previous adefovir and lamivudine treatment.
Topics: Adenine; Adult; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Chronic Disease; DNA-Directed DNA Polymerase; Hepatitis B; Hepatitis B virus; HIV Infections; Humans; Lamivudine; Male; Mutation; Organophosphonates; Reverse Transcriptase Inhibitors; Tenofovir; Treatment Outcome; Viral Load | 2004 |
Refractory human papillomavirus-associated oral warts treated topically with 1-3% cidofovir solutions in human immunodeficiency virus type 1-infected patients.
Topics: Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Cytosine; HIV-1; Humans; Male; Middle Aged; Mouth Diseases; Organophosphonates; Papillomaviridae; Warts | 2005 |
Safety and efficacy of adefovir dipivoxil in patients infected with lamivudine-resistant hepatitis B and HIV-1.
Topics: Adenine; Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Drug Resistance, Viral; Female; Follow-Up Studies; Hepatitis B virus; Hepatitis B, Chronic; HIV-1; Humans; Lamivudine; Male; Organophosphonates; Pilot Projects; Polymerase Chain Reaction; Prospective Studies; RNA, Viral; Treatment Outcome | 2006 |
Treatment of lamivudine-resistant hepatitis B in HIV-infected persons: is adefovir dipivoxil the answer?
Topics: Adenine; AIDS-Related Opportunistic Infections; Antiviral Agents; DNA, Viral; Drug Resistance, Viral; Hepatitis B Antibodies; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; HIV; HIV Antibodies; Humans; Lamivudine; Organophosphonates; Treatment Outcome | 2006 |
Cidofovir treatment of HIV-associated cytomegalovirus polyradiculopathy.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Cidofovir; Cytomegalovirus Infections; Cytosine; Drug Therapy, Combination; Female; Humans; Organophosphonates; Polyradiculopathy | 2006 |
Risk of immune recovery uveitis in patients with AIDS and cytomegalovirus retinitis.
Topics: Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; Cidofovir; Cross-Sectional Studies; Cytomegalovirus Retinitis; Cytosine; Female; Humans; Injections; Male; Organophosphonates; Prevalence; Risk Factors; Uveitis, Posterior; Visual Acuity; Vitreous Body | 2006 |
Remission of AIDS-associated progressive multifocal leukoencephalopathy with combined cidofovir and radiotherapy: a case report.
Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Combined Modality Therapy; Cytosine; Humans; Leukoencephalopathy, Progressive Multifocal; Male; Middle Aged; Organophosphonates | 2006 |
Visual loss secondary to acquired immunodeficiency virus-related progressive multifocal leukoencephalopathy demonstrating clinical improvement with highly active antiretroviral therapy.
Topics: Adenine; AIDS-Related Opportunistic Infections; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; Cerebrospinal Fluid; Cyclopropanes; Drug Therapy, Combination; Hemianopsia; Humans; JC Virus; Lamivudine; Leukoencephalopathy, Progressive Multifocal; Magnetic Resonance Imaging; Male; Middle Aged; Organophosphonates; Oxazines; Tenofovir; Tomography, X-Ray Computed; Vision Disorders; Visual Fields | 2007 |
Chlorpromazine combined with cidofovir for treatment of a patient suffering from progressive multifocal leukoencephalopathy.
Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Brain; Chlorpromazine; Cidofovir; Cytosine; DNA, Viral; Drug Therapy, Combination; Fatal Outcome; Humans; JC Virus; Leukoencephalopathy, Progressive Multifocal; Magnetic Resonance Imaging; Male; Middle Aged; Organophosphonates | 2007 |
1% topical cidofovir used as last alternative to treat viral infections.
Topics: Administration, Topical; Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Cytosine; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Molluscum Contagiosum; Organophosphonates; Papillomavirus Infections | 2008 |
Clinical pharmacokinetics of cidofovir in human immunodeficiency virus-infected patients.
Topics: Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Cytomegalovirus Infections; Cytosine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; HIV Infections; Humans; Immunocompromised Host; Kidney; Kidney Function Tests; Male; Metabolic Clearance Rate; Middle Aged; Organophosphonates; Organophosphorus Compounds; Probenecid | 1995 |
Treatment of anogenital papillomavirus infections with an acyclic nucleoside phosphonate analogue.
Topics: Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Condylomata Acuminata; Cytosine; Female; Humans; Male; Organophosphonates; Organophosphorus Compounds; Papillomaviridae | 1995 |
AIDS therapy. New hope against blindness.
Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Blindness; Cidofovir; Clinical Trials as Topic; Cytomegalovirus Retinitis; Cytosine; Drug Implants; Ganciclovir; Humans; Organophosphonates; Organophosphorus Compounds; RNA, Antisense | 1995 |
Successful treatment of progressive mucocutaneous infection due to acyclovir- and foscarnet-resistant herpes simplex virus with (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine (HPMPC).
Topics: Acyclovir; Administration, Topical; Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Cytosine; DNA Restriction Enzymes; DNA, Viral; Drug Resistance, Microbial; Foscarnet; Herpes Genitalis; Herpes Simplex; Herpesvirus 1, Human; Herpesvirus 2, Human; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Opportunistic Infections; Organophosphonates; Organophosphorus Compounds; Skin Diseases, Viral; Thymidine Kinase | 1994 |
Treatment with intravenous (S)-1-[3-hydroxy-2-(phosphonylmethoxy)propyl]-cytosine of acyclovir-resistant mucocutaneous infection with herpes simplex virus in a patient with AIDS.
Topics: Acyclovir; AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Cytosine; Drug Resistance, Microbial; Herpes Simplex; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Organophosphonates; Organophosphorus Compounds; Simplexvirus | 1994 |
A new topical treatment for resistant herpes simplex infections.
Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Cytosine; Drug Resistance; Herpes Simplex; Humans; Immunocompromised Host; Organophosphonates; Organophosphorus Compounds; Simplexvirus | 1993 |
Distribution and metabolism of intravitreal cidofovir and cyclic HPMPC in rabbits.
Topics: AIDS-Related Opportunistic Infections; Animals; Antiviral Agents; Cidofovir; Cytomegalovirus Retinitis; Cytosine; Eye; Half-Life; Humans; Injections; Kidney; Male; Organophosphonates; Organophosphorus Compounds; Rabbits; Retina; Tissue Distribution; Vitreous Body | 1996 |
Treatment of cytomegalovirus retinitis in patients with AIDS.
Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Cytomegalovirus Infections; Cytosine; Drug Administration Routes; Foscarnet; Ganciclovir; Humans; Organophosphonates; Organophosphorus Compounds; Retinitis | 1996 |
Treatment of cytomegalovirus retinitis with intravitreous cidofovir in patients with AIDS. A preliminary report.
Topics: Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Cytomegalovirus Infections; Cytosine; Disease Progression; Female; Humans; Injections, Intralesional; Male; Middle Aged; Organophosphonates; Organophosphorus Compounds; Prospective Studies; Retinitis; Treatment Outcome; Vitreous Body | 1996 |
Intravitreal cidofovir for the maintenance treatment of cytomegalovirus retinitis.
Topics: Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Cytomegalovirus Retinitis; Cytosine; Disease Progression; Female; Follow-Up Studies; Humans; Injections; Male; Organophosphonates; Organophosphorus Compounds; Prospective Studies; Retinal Detachment; Safety; Survival Rate; Vitreous Body | 1996 |
New developments in the treatment of CMV retinitis.
Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Cytomegalovirus Retinitis; Cytosine; Foscarnet; Ganciclovir; Humans; Injections; Injections, Intravenous; Organophosphonates; Organophosphorus Compounds; Vitreous Body | 1996 |
Cidofovir for AIDS-related retinitis.
Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Cytomegalovirus Retinitis; Cytosine; Disease Progression; Humans; Organophosphonates; Organophosphorus Compounds; Treatment Outcome | 1996 |
More new drugs for HIV and associated infections.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Anti-Bacterial Agents; Antiviral Agents; Cidofovir; Clinical Trials as Topic; Cytomegalovirus Retinitis; Cytosine; HIV Infections; Humans; Isoquinolines; Nelfinavir; Nevirapine; Organophosphonates; Organophosphorus Compounds; Protease Inhibitors; Pyridines; Ritonavir; Sulfonic Acids | 1997 |
New therapies for cytomegalovirus retinitis in patients with the acquired immunodeficiency syndrome.
Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Cytomegalovirus Infections; Cytosine; Foscarnet; Ganciclovir; Humans; Organophosphonates; Organophosphorus Compounds; Prognosis; Retinitis | 1997 |
Low-dose intravitreal cidofovir (HPMPC) therapy of cytomegalovirus retinitis in patients with acquired immune deficiency syndrome.
Topics: Adolescent; Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Cytomegalovirus Retinitis; Cytosine; Disease Progression; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Fundus Oculi; Humans; Injections; Male; Middle Aged; Organophosphonates; Organophosphorus Compounds; Retrospective Studies; Treatment Outcome; Vitreous Body | 1997 |
Successful use of cidofovir in treating AIDS-related cytomegalovirus retinitis, encephalitis, and esophagitis.
Topics: Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Cytomegalovirus Infections; Cytosine; Encephalitis, Viral; Esophagitis; Humans; Male; Organophosphonates; Organophosphorus Compounds; Retinitis | 1997 |
Successful treatment of cytomegalovirus encephalitis in an AIDS patient using cidofovir.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Cytomegalovirus Infections; Cytomegalovirus Retinitis; Cytosine; Encephalitis, Viral; Humans; Magnetic Resonance Imaging; Male; Organophosphonates; Organophosphorus Compounds; Treatment Outcome | 1997 |
Evolution of mutations conferring multidrug resistance during prophylaxis and therapy for cytomegalovirus disease.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antiviral Agents; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; Drug Resistance, Microbial; Drug Resistance, Multiple; Drug Therapy, Combination; Foscarnet; Ganciclovir; Humans; Male; Mutation; Organophosphonates; Organophosphorus Compounds; Phosphotransferases (Alcohol Group Acceptor); Recombination, Genetic; RNA-Directed DNA Polymerase; Sequence Analysis, DNA | 1997 |
Recurrent iritis after intravenous administration of cidofovir.
Topics: Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; CD4 Lymphocyte Count; Cidofovir; Cytomegalovirus Retinitis; Cytosine; Humans; Iritis; Male; Organophosphonates; Organophosphorus Compounds; Recurrence | 1997 |
Ophthalmic complications of HIV/AIDS.
Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Cytomegalovirus Retinitis; Cytosine; Humans; Organophosphonates; Organophosphorus Compounds | 1997 |
Adverse events and autopsy findings after intravitreous cidofovir (HPMPC) therapy in patients with acquired immune deficiency syndrome (AIDS).
Topics: Adult; AIDS-Related Opportunistic Infections; Anterior Eye Segment; Antiviral Agents; Autopsy; Cidofovir; Cytomegalovirus Retinitis; Cytosine; Female; Follow-Up Studies; Fundus Oculi; Humans; Injections; Iritis; Male; Middle Aged; Ocular Hypotension; Organophosphonates; Organophosphorus Compounds; Pigment Epithelium of Eye; Prospective Studies; Vitreous Body | 1997 |
[More successful therapy of CMV retinitis in AIDS patients].
Topics: AIDS-Related Opportunistic Infections; Anti-HIV Agents; Cidofovir; Cytomegalovirus Retinitis; Cytosine; HIV-1; Humans; Organophosphonates; Organophosphorus Compounds | 1997 |
Clinical failure of CMV retinitis with intravitreal cidofovir is associated with antiviral resistance.
Topics: Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Cytomegalovirus; Cytomegalovirus Retinitis; Cytosine; DNA, Viral; Drug Resistance, Microbial; Ganciclovir; Humans; Injections; Male; Middle Aged; Organophosphonates; Organophosphorus Compounds; Polymerase Chain Reaction; Treatment Failure; Vitreous Body | 1998 |
New issues in the management of cytomegalovirus retinitis in AIDS patients.
Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Cytomegalovirus Retinitis; Cytosine; Drug Implants; Foscarnet; Ganciclovir; Humans; Organophosphonates; Organophosphorus Compounds | 1998 |
New treatments for progressive multifocal leukoencephalopathy in HIV-1-infected patients.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Cidofovir; Cytosine; Drug Therapy, Combination; HIV Infections; Humans; Leukoencephalopathy, Progressive Multifocal; Magnetic Resonance Imaging; Male; Middle Aged; Organophosphonates; Organophosphorus Compounds; Treatment Outcome | 1998 |
Anterior uveitis and hypotony after intravenous cidofovir for the treatment of cytomegalovirus retinitis.
Topics: Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; CD4 Lymphocyte Count; Cidofovir; Cohort Studies; Cytomegalovirus Retinitis; Cytosine; Female; Humans; Incidence; Injections, Intravenous; Intraocular Pressure; Male; Middle Aged; Ocular Hypotension; Organophosphonates; Organophosphorus Compounds; Retrospective Studies; Risk Factors; Treatment Outcome; Uveitis, Anterior | 1998 |
Adenovirus cholecystitis in a patient with AIDS.
Topics: Adenoviridae Infections; Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Cholecystitis; Cidofovir; Cytosine; Humans; Male; Organophosphonates; Organophosphorus Compounds | 1998 |
Lack of efficacy of cidofovir in treating AIDS-related cytomegalovirus retinitis after long-term treatment with ganciclovir.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Cidofovir; Cytomegalovirus Retinitis; Cytosine; Foscarnet; Ganciclovir; Humans; Male; Organophosphonates; Organophosphorus Compounds; Recurrence | 1998 |
Guidelines for the treatment of cytomegalovirus diseases in patients with AIDS in the era of potent antiretroviral therapy: recommendations of an international panel. International AIDS Society-USA.
Topics: AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antiviral Agents; Cidofovir; Cytomegalovirus Infections; Cytosine; Foscarnet; Ganciclovir; Humans; Lung Diseases; Nervous System Diseases; Organophosphonates; Organophosphorus Compounds; Retinitis | 1998 |
Lack of reactivation of cytomegalovirus (CMV) retinitis after stopping CMV maintenance therapy in AIDS patients with sustained elevations in CD4 T cells in response to highly active antiretroviral therapy.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antiviral Agents; CD4 Lymphocyte Count; Cidofovir; Cytomegalovirus; Cytomegalovirus Retinitis; Cytosine; Drug Therapy, Combination; Female; HIV Protease Inhibitors; HIV-1; Humans; Male; Organophosphonates; Organophosphorus Compounds; Recurrence; Virus Activation; Virus Replication | 1998 |
[Fabrication of cidofovir ampules for intravitreal injections for cytomegalovirus retinitis].
Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Chemistry, Pharmaceutical; Cidofovir; Cytomegalovirus Retinitis; Cytosine; Drug Compounding; Drug Packaging; Humans; Injections; Male; Middle Aged; Organophosphonates; Organophosphorus Compounds; Vitreous Body | 1998 |
Abatement of cutaneous Kaposi's sarcoma associated with cidofovir treatment.
Topics: Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Cytomegalovirus Retinitis; Cytosine; Herpesvirus 8, Human; Humans; Male; Organophosphonates; Organophosphorus Compounds; Sarcoma, Kaposi; Skin Neoplasms | 1998 |
Cytomegalovirus retinitis and viral resistance: 3. Culture results. CMV Retinitis and Viral Resistance Study Group.
Topics: Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Baltimore; Blood; Cidofovir; Cytomegalovirus; Cytomegalovirus Retinitis; Cytosine; Drug Resistance, Microbial; Female; Follow-Up Studies; Foscarnet; Ganciclovir; Humans; Male; Organophosphonates; Organophosphorus Compounds; Prognosis; Prospective Studies; Survival Rate; Urine; Viremia | 1998 |
[Intravitreal injection of cidofovir in cytomegalovirus retinitis].
Topics: Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Cytomegalovirus Retinitis; Cytosine; Female; Humans; Injections; Male; Middle Aged; Organophosphonates; Organophosphorus Compounds; Vitreous Body | 1998 |
Prognostic value of JC virus load in cerebrospinal fluid of patients with progressive multifocal leukoencephalopathy.
Topics: AIDS Dementia Complex; AIDS-Related Opportunistic Infections; Antiviral Agents; CD4 Lymphocyte Count; Cidofovir; Cytosine; DNA Primers; DNA Probes; DNA, Viral; Female; HIV-1; Humans; JC Virus; Male; Organophosphonates; Organophosphorus Compounds; Papillomavirus Infections; Polymerase Chain Reaction; Predictive Value of Tests; Prognosis; Statistics, Nonparametric; Tumor Virus Infections; Viral Load | 1998 |
Cytomegalovirus iritis.
Topics: Adult; AIDS-Related Opportunistic Infections; Antibodies, Viral; Antigens, Viral; Antiviral Agents; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytomegalovirus Retinitis; Cytosine; Fatal Outcome; Humans; Immunohistochemistry; Iris; Iritis; Male; Organophosphonates; Organophosphorus Compounds | 1998 |
Discontinuing anticytomegalovirus therapy in patients with immune reconstitution after combination antiretroviral therapy.
Topics: Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; Cidofovir; Cytomegalovirus Retinitis; Cytosine; Drug Implants; Drug Therapy, Combination; Female; Ganciclovir; HIV-1; Humans; Male; Middle Aged; Organophosphonates; Organophosphorus Compounds; Viral Load | 1998 |
Abatement of cutaneous Kaposi's sarcoma associated with cidofovir treatment.
Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Cytosine; Humans; Organophosphonates; Organophosphorus Compounds; Sarcoma, Kaposi; Skin Neoplasms | 1998 |
Incidence of immune recovery vitritis in cytomegalovirus retinitis patients following institution of successful highly active antiretroviral therapy.
Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; California; Cidofovir; Cohort Studies; Cytomegalovirus Retinitis; Cytosine; Eye Diseases; Follow-Up Studies; Humans; Incidence; Inflammation; Organophosphonates; Organophosphorus Compounds; Prospective Studies; Retrospective Studies; Syndrome; Time Factors; Visual Acuity; Vitreous Body | 1999 |
Vitrectomy and silicone oil tamponade for cidofovir-associated hypotony with ciliary body detachment.
Topics: AIDS-Related Opportunistic Infections; Cidofovir; Ciliary Body; Cytomegalovirus Retinitis; Cytosine; Eye Diseases; Humans; Lens Implantation, Intraocular; Lens, Crystalline; Male; Middle Aged; Ocular Hypotension; Organophosphonates; Organophosphorus Compounds; Silicone Oils; Ultrasonography; Vitrectomy | 1999 |
Response to cidofovir after failure of antiretroviral therapy alone in AIDS-associated progressive multifocal leukoencephalopathy.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antiviral Agents; Brain; Cidofovir; Cytosine; Female; Humans; Leukoencephalopathy, Progressive Multifocal; Magnetic Resonance Imaging; Organophosphonates; Organophosphorus Compounds | 1999 |
Iritis associated with intravenous cidofovir.
Topics: Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Cytomegalovirus Retinitis; Cytosine; Humans; Infusions, Intravenous; Iritis; Male; Organophosphonates; Organophosphorus Compounds | 1999 |
Surgical repair of cytomegalovirus-related retinal detachment without silicone oil in patients with AIDS.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-HIV Agents; CD4 Lymphocyte Count; Cidofovir; Cytomegalovirus Retinitis; Cytosine; Female; Fluorocarbons; Follow-Up Studies; HIV-1; Humans; Laser Coagulation; Male; Organophosphonates; Organophosphorus Compounds; Retinal Detachment; Scleral Buckling; Silicone Oils; Sulfur Hexafluoride; Visual Acuity; Vitrectomy | 1999 |
Prolonged survival without neurological improvement in patients with AIDS-related progressive multifocal leukoencephalopathy on potent combined antiretroviral therapy.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-HIV Agents; CD4 Lymphocyte Count; Cidofovir; Cytosine; Demyelinating Diseases; Female; France; HIV; HIV Long-Term Survivors; HIV Protease Inhibitors; Humans; JC Virus; Leukoencephalopathy, Progressive Multifocal; Male; Middle Aged; Organophosphonates; Organophosphorus Compounds; Polymerase Chain Reaction; Prospective Studies; Retrospective Studies; Survival Rate; Time Factors; Viral Load | 1999 |
Anterior uveitis associated with intravenous cidofovir use in patients with cytomegalovirus retinitis.
Topics: Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Case-Control Studies; CD4 Lymphocyte Count; Cidofovir; Cytomegalovirus Retinitis; Cytosine; Female; Humans; Male; Middle Aged; Organophosphonates; Organophosphorus Compounds; Retrospective Studies; Risk Factors; Uveitis, Anterior | 1999 |
Intralesional or topical cidofovir (HPMPC, VISTIDE) for the treatment of recurrent genital warts in HIV-1-infected patients.
Topics: Administration, Topical; AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Condylomata Acuminata; Cytosine; DNA, Viral; HIV; Humans; Organophosphonates; Organophosphorus Compounds; Papillomaviridae; Papillomavirus Infections; Recurrence; Tumor Virus Infections; Viral Load | 1999 |
Management of progressive outer retinal necrosis with cidofovir in a human immunodeficiency virus-infected patient.
Topics: Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Cytosine; Herpes Zoster; Humans; Injections, Intravenous; Male; Organophosphonates; Organophosphorus Compounds; Retinal Necrosis Syndrome, Acute; Severity of Illness Index; Treatment Outcome | 1999 |
Cystoid macular edema following immune recovery and treatment with cidofovir for cytomegalovirus retinitis.
Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; CD4 Lymphocyte Count; Cidofovir; Cytomegalovirus Retinitis; Cytosine; Fluorescein Angiography; Follow-Up Studies; Fundus Oculi; Humans; Injections, Intravenous; Macular Edema; Organophosphonates; Organophosphorus Compounds; Retrospective Studies; Vitreous Body | 1999 |
Intravenous cidofovir for compassionate use in AIDS patients with cytomegalovirus retinitis. Spanish Cidofovir Study Group.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antiviral Agents; Cidofovir; Cohort Studies; Cytomegalovirus Retinitis; Cytosine; Drug Therapy, Combination; Female; Humans; Male; Organophosphonates; Organophosphorus Compounds; Treatment Outcome | 2000 |
Successful resolution of progressive multifocal leukoencephalopathy after combination therapy with cidofovir and cytosine arabinoside.
Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Cytarabine; Cytosine; Drug Therapy, Combination; Humans; Leukoencephalopathy, Progressive Multifocal; Organophosphonates; Organophosphorus Compounds; Treatment Outcome | 2000 |
Ocular complications of intravenous cidofovir for cytomegalovirus retinitis in patients with AIDS.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-HIV Agents; CD4 Lymphocyte Count; Cidofovir; Cytomegalovirus Retinitis; Cytosine; Female; Humans; Male; Middle Aged; Ocular Hypotension; Organophosphonates; Organophosphorus Compounds; Retrospective Studies; Uveitis, Anterior | 1999 |
Cidofovir ocular toxicity is related to previous ocular history.
Topics: Adult; Aged; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Cataract Extraction; Cidofovir; Cytosine; Female; Humans; Leukoencephalopathy, Progressive Multifocal; Male; Mydriatics; Organophosphonates; Organophosphorus Compounds; Uveitis | 2000 |
Topical cidofovir is effective in treating extensive penile condylomata acuminata.
Topics: Administration, Topical; Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Condylomata Acuminata; Cytosine; Humans; Male; Organophosphonates; Organophosphorus Compounds; Penile Diseases | 2000 |
Lack of reactivation of cytomegalovirus retinitis in an AIDS patient, during and after stopping long-term cidofovir treatment: case report.
Topics: Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Cytomegalovirus; Cytomegalovirus Retinitis; Cytosine; Drug Administration Schedule; Humans; Male; Organophosphonates; Organophosphorus Compounds; Virus Activation | 2000 |
Large plantar wart caused by human papillomavirus-66 and resolution by topical cidofovir therapy.
Topics: Administration, Topical; Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Biopsy; Cidofovir; Cytosine; Diagnosis, Differential; DNA, Viral; Female; Foot Dermatoses; Humans; Male; Organophosphonates; Organophosphorus Compounds; Papillomaviridae; Papillomavirus Infections; Polymerase Chain Reaction; Skin; Warts | 2000 |
Topical cidofovir: a novel treatment for recalcitrant molluscum contagiosum in children infected with human immunodeficiency virus 1.
Topics: Administration, Topical; AIDS-Related Opportunistic Infections; Antiviral Agents; Child; Child, Preschool; Cidofovir; Cytosine; Drug Administration Schedule; Facial Dermatoses; HIV-1; Humans; Male; Molluscum Contagiosum; Organophosphonates; Organophosphorus Compounds; Perineum | 2000 |
[Stopping secondary prevention in AIDS patients with inactive CMV retinitis treated with HAART (highly active antiretroviral therapy)].
Topics: AIDS-Related Opportunistic Infections; Antiretroviral Therapy, Highly Active; Antiviral Agents; Cidofovir; Cytomegalovirus Retinitis; Cytosine; Follow-Up Studies; Foscarnet; Ganciclovir; Humans; Organophosphonates; Organophosphorus Compounds | 2000 |
Ocular side-effects from systemic HPMPC (Cidofovir) for a non-ocular cytomegalovirus infection.
Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Cytomegalovirus Infections; Cytosine; Drug Therapy, Combination; Humans; Intraocular Pressure; Male; Middle Aged; Ocular Hypotension; Organophosphonates; Organophosphorus Compounds; Probenecid; Uveitis, Anterior | 2000 |
Progressive multifocal leukoencephalopathy treated with cidofovir in HIV-infected patients receiving highly active anti-retroviral therapy.
Topics: Adult; AIDS-Related Opportunistic Infections; Antiretroviral Therapy, Highly Active; Antiviral Agents; Cidofovir; Cytosine; Female; HIV Infections; HIV-1; Humans; Leukoencephalopathy, Progressive Multifocal; Male; Organophosphonates; Organophosphorus Compounds | 2000 |
[Severe alopecia caused by cidofovir]].
Topics: Adult; AIDS-Related Opportunistic Infections; Alopecia; Antiviral Agents; Cidofovir; Cytomegalovirus Retinitis; Cytosine; Humans; Male; Organophosphonates; Organophosphorus Compounds | 2000 |
Long-term remission of an AIDS-related primary effusion lymphoma with antiviral therapy.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Antineoplastic Agents; Antiretroviral Therapy, Highly Active; Antiviral Agents; Burkitt Lymphoma; Cidofovir; Cytosine; Herpesvirus 4, Human; Herpesvirus 8, Human; HIV Long-Term Survivors; HIV Protease Inhibitors; Humans; Interferon-alpha; Lymphoma, B-Cell; Male; Organophosphonates; Organophosphorus Compounds; Pleural Effusion; Sarcoma, Kaposi; Time Factors | 2001 |
FDA grants marketing clearance of Vistide for the treatment of CMV retinitis.
Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Cytomegalovirus Retinitis; Cytosine; Drug Approval; Humans; Organophosphonates; Organophosphorus Compounds; United States; United States Food and Drug Administration | 1996 |
CMV retinitis: a clinical management update.
Topics: AIDS-Related Opportunistic Infections; Algorithms; Antiviral Agents; Cidofovir; Clinical Protocols; Clinical Trials as Topic; Cytomegalovirus; Cytomegalovirus Retinitis; Cytosine; Drug Implants; Drug Resistance, Microbial; Drug Therapy, Combination; Foscarnet; Ganciclovir; Humans; Injections; Organophosphonates; Organophosphorus Compounds; Patient Participation; Vitreous Body | 1996 |
Pharmacia and Upjohn and Gilead sciences receive European recommendation for cidofovir.
Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Cytomegalovirus Retinitis; Cytosine; Drug Administration Schedule; Drug Industry; Europe; Humans; Infusions, Intravenous; Organophosphonates; Organophosphorus Compounds; Product Surveillance, Postmarketing | 1997 |
Gilead announces phase I/II data insufficient for marketing clearance of FORVADE topical gel to treat refractory herpes in patients with AIDS.
Topics: Administration, Topical; AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Cytosine; Herpes Simplex; Humans; Investigational New Drug Application; Organophosphonates; Organophosphorus Compounds; United States; United States Food and Drug Administration | 1997 |
Advances in the treatment of CMV.
Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Clinical Trials, Phase I as Topic; Clinical Trials, Phase III as Topic; Cytomegalovirus Retinitis; Cytosine; Drug Implants; Drug Therapy, Combination; Eye; Foscarnet; Ganciclovir; Humans; Organophosphonates; Organophosphorus Compounds; Quality of Life | 1995 |
Cidofovir approved.
Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Cytomegalovirus Retinitis; Cytosine; Drug Administration Schedule; Humans; Organophosphonates; Organophosphorus Compounds; Quality of Life | 1996 |
Anti-HIV agents at ICAAC.
Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; CD4 Lymphocyte Count; Cidofovir; Cytomegalovirus Retinitis; Cytosine; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Isoquinolines; Kidney; Mutation; Nelfinavir; Organophosphonates; Organophosphorus Compounds; Reverse Transcriptase Inhibitors; Ritonavir; Saquinavir; Sulfonic Acids; Treatment Failure; Viral Load | 1996 |
Fomivirsen.
Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Clinical Trials as Topic; Cytomegalovirus Retinitis; Cytosine; Disease Progression; Foscarnet; Ganciclovir; Health Services Accessibility; Humans; Organophosphonates; Organophosphorus Compounds; Thionucleotides | 1998 |
Cidofovir.
Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Cytomegalovirus Retinitis; Cytosine; Drug Interactions; Drug Therapy, Combination; Humans; Injections, Intravenous; Organophosphonates; Organophosphorus Compounds; Probenecid; Uricosuric Agents | 1998 |
A rocky road for nucleotide analogs.
Topics: Adenine; AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Clinical Trials as Topic; Cytomegalovirus Retinitis; Cytosine; HIV Infections; Humans; Organophosphonates; Organophosphorus Compounds | 1998 |
[Anterior uveitis and cidofovir].
Topics: Adult; AIDS-Related Opportunistic Infections; CD4 Lymphocyte Count; Cidofovir; Creatinine; Cytomegalovirus Retinitis; Cytosine; Female; Humans; Male; Metabolic Clearance Rate; Middle Aged; Ophthalmoscopy; Organophosphonates; Organophosphorus Compounds; Recurrence; Retrospective Studies; Time Factors; Tissue Distribution; Uveitis, Anterior | 2001 |
Successful treatment of aids related PML with HAART and cidofovir.
Topics: Aged; AIDS-Related Opportunistic Infections; Antiretroviral Therapy, Highly Active; Antiviral Agents; Brain; Cidofovir; Cytosine; Female; Humans; Leukoencephalopathy, Progressive Multifocal; Magnetic Resonance Imaging; Organophosphonates; Organophosphorus Compounds | 2001 |
The good and evil of HAART in HIV-related progressive multifocal leukoencephalopathy.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Cidofovir; Cytosine; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Leukoencephalopathy, Progressive Multifocal; Male; Middle Aged; Organophosphonates; Organophosphorus Compounds; Retrospective Studies; Survival Analysis | 2001 |
Efficacy of cidofovir on human herpesvirus 8 viraemia and Kaposi's sarcoma progression in two patients with AIDS.
Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Cytosine; Disease Progression; DNA, Viral; Herpesvirus 8, Human; Humans; Organophosphonates; Organophosphorus Compounds; Sarcoma, Kaposi; Skin Neoplasms; Treatment Outcome; Viremia | 2001 |
Cidofovir.
Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; CD4 Lymphocyte Count; Cidofovir; Cytosine; Humans; Leukoencephalopathy, Progressive Multifocal; Organophosphonates; Organophosphorus Compounds | 2001 |
Cidofovir treatment of progressive multifocal leukoencephalopathy in a patient receiving highly active antiretroviral therapy.
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Opportunistic Infections; Antiretroviral Therapy, Highly Active; Antiviral Agents; Cidofovir; Cytosine; Humans; Leukoencephalopathy, Progressive Multifocal; Male; Middle Aged; Organophosphonates; Organophosphorus Compounds; Treatment Outcome | 2001 |
Treatment of severe ocular hypotony in AIDS patients with cytomegalovirus retinitis and cidofovir-associated uveitis.
Topics: AIDS-Related Opportunistic Infections; Animals; Antiviral Agents; Cidofovir; Cytomegalovirus Retinitis; Cytosine; Deoxyepinephrine; Dexamethasone; Dopamine Agonists; Drug Therapy, Combination; Glucocorticoids; Humans; Intraocular Pressure; Ocular Hypotension; Ophthalmic Solutions; Organophosphonates; Organophosphorus Compounds; Uveitis, Anterior | 2001 |
Treatment of severe ocular hypotony in AIDS patients with cytomegalovirus retinitis and cidofovir-associated uveitis.
Topics: Adult; AIDS-Related Opportunistic Infections; Antiretroviral Therapy, Highly Active; Antiviral Agents; Cidofovir; Cytomegalovirus Retinitis; Cytosine; Deoxyepinephrine; Dexamethasone; Dopamine Agonists; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Intraocular Pressure; Ocular Hypotension; Ophthalmic Solutions; Organophosphonates; Organophosphorus Compounds; Uveitis, Anterior | 2001 |
Cidofovir: progress in the treatment of progressive multifocal encephalopathy (PML)?
Topics: AIDS-Related Opportunistic Infections; Antiretroviral Therapy, Highly Active; Antiviral Agents; CD4 Lymphocyte Count; Cidofovir; Cytosine; Disease Progression; Humans; Leukoencephalopathy, Progressive Multifocal; Organophosphonates; Organophosphorus Compounds; Viral Load | 2002 |
Resolution of recurrent perianal condylomata acuminata by topical cidofovir in patients with HIV infection.
Topics: Administration, Topical; Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Condylomata Acuminata; Cytosine; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Male; Organophosphonates; Organophosphorus Compounds; Recurrence; Severity of Illness Index; Skin Diseases, Viral; Treatment Outcome | 2001 |
Herpes simplex virus isolates with reduced adefovir susceptibility selected in vivo by foscarnet therapy.
Topics: Adenine; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Foscarnet; Herpes Genitalis; Herpes Simplex; Herpesvirus 1, Human; Herpesvirus 2, Human; HIV Infections; Humans; Organophosphonates; Reverse Transcriptase Inhibitors | 2002 |
A case of flare syndrome.
Topics: Acute Disease; Adult; AIDS-Related Opportunistic Infections; Antiretroviral Therapy, Highly Active; Antiviral Agents; CD4 Lymphocyte Count; Cidofovir; Cytomegalovirus Retinitis; Cytosine; Drug Therapy, Combination; Ganciclovir; HIV Infections; Humans; Indinavir; Lamivudine; Male; Organophosphonates; Organophosphorus Compounds; Zidovudine | 2001 |
Successful treatment of an aciclovir-resistant herpes simplex type 2 infection with cidofovir in an AIDS patient.
Topics: Acyclovir; Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Cytosine; Drug Resistance, Viral; Female; Fissure in Ano; Herpes Simplex; Herpesvirus 2, Human; Humans; Organophosphonates; Organophosphorus Compounds | 2002 |